Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cullgen
AddedFeb 15, 2024
UpdatedJun 18, 2026
Cullgen

Cullgen

Cullgen: A biopharmaceutical firm innovating novel therapies for previously untreatable diseases.

HQ
San Diego, CA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Cullgen, founded by Ying Luo, Ph.D., is a biopharmaceutical company dedicated to developing novel therapies for diseases that currently lack effective treatments. The company's core mission is to revolutionize medicine by leveraging protein degradation technology to selectively target and degrade disease-causing proteins, including those previously considered undruggable. Cullgen's primary focus is on creating innovative treatments for cancer, inflammatory, and autoimmune diseases through their proprietary uSMITE™ platform.

Notable figures affiliated with Cullgen include CEO Ying Luo, Ph.D., who leads the company's vision of expanding the drug design paradigm. Cullgen has garnered attention for its groundbreaking approach to targeted protein degradation, positioning itself as a leader in the biopharmaceutical industry. The company's impact lies in its potential to provide new therapeutic options for debilitating diseases, thereby transforming patient outcomes and advancing medical science.

Cullgen - Similar Companies

Cullinan Oncology logo

Cullinan Oncology

C4 Therapeutics logo

C4 Therapeutics

c4therapeutics.com

Cargene logo

Cargene

cargene.com

EpiBiologics logo

EpiBiologics

epibiologics.com

CuraSen Therapeutics logo

CuraSen Therapeutics

curasen.com

Generate Biomedicines logo

Generate Biomedicines

76Bio logo

76Bio

76bio.com

Cue Biopharma logo

Cue Biopharma

BridGene Biosciences logo

BridGene Biosciences

Kymera Therapeutics logo

Kymera Therapeutics

kymeratx.com

Celsius Therapeutics logo

Celsius Therapeutics

celsiustx.com

Innovo Therapeutics logo

Innovo Therapeutics

Chlorogen logo

Chlorogen

chlorogen.com

Culmination Bio logo

Culmination Bio

culmination.com

Spheringenics logo

Spheringenics

Cullgen - Quick Facts

Who are Cullgen's competitors?

Companies similar to Cullgen include Cullinan Oncology, C4 Therapeutics, Cargene and EpiBiologics.

When was Cullgen founded?

Cullgen was founded in 2018.

Where is Cullgen's headquarters located?

Cullgen's headquarters is located in San Diego, CA, US.

When was Cullgen's last funding round?

Cullgen's most recent funding round was for $5M (USD) in May 2023.

How much has Cullgen raised to-date?

As of May 8, 2023, Cullgen has raised a total of $106M (USD).

How many employees does Cullgen have?

Cullgen has 125 employees as of Feb 4, 2024.

Cullgen - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Biopharmaceuticals
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified